FGEN: Fibrogen Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Fibrogen Inc (FGEN).

OverviewDividends

$53.36M Market Cap.

As of 06/17/2025 5:00 PM ET (MRY) • Disclaimer

FGEN Market Cap. (MRY)


FGEN Shares Outstanding (MRY)


FGEN Assets (MRY)


Total Assets

$214.53M

Total Liabilities

$398.16M

Total Investments

$0

FGEN Income (MRY)


Revenue

$29.62M

Net Income

-$47.58M

Operating Expense

$164.48M

FGEN Cash Flow (MRY)


CF Operations

-$138.00M

CF Investing

$125.99M

CF Financing

-$255.00K

FGEN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$214,525,000 (-49.35%)

$423,529,000 (-30.58%)

$610,087,000 (-21.16%)

$773,821,000 (-6.41%)

Assets Current

$196,509,000 (-40.73%)

$331,559,000 (-32.72%)

$492,826,000 (3.96%)

$474,059,000 (-37.22%)

Assets Non-Current

$18,016,000 (-80.41%)

$91,970,000 (-21.57%)

$117,261,000 (-60.88%)

$299,762,000 (317.90%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$225,602,000 (-10.50%)

-$204,166,000 (-851.96%)

-$21,447,000 (-110.25%)

$209,146,000 (-50.46%)

Property Plant & Equipment Net

$0 (0%)

$69,724,000 (-30.62%)

$100,498,000 (-15.82%)

$119,389,000 (82.84%)

Cash & Equivalents

$50,482,000 (-38.10%)

$81,553,000 (-47.62%)

$155,700,000 (-9.07%)

$171,223,000 (-74.76%)

Accumulated Other Comprehensive Income

-$5,732,000 (16.63%)

-$6,875,000 (-20.19%)

-$5,720,000 (-37.40%)

-$4,163,000 (7.47%)

Deferred Revenue

$141,998,000 (-16.62%)

$170,295,000 (-14.19%)

$198,461,000 (-2.07%)

$202,658,000 (39.74%)

Total Investments

$0 (0%)

$123,556,000 (-55.52%)

$277,789,000 (-31.86%)

$407,660,000 (2991.14%)

Investments Current

$0 (0%)

$121,898,000 (-54.23%)

$266,308,000 (13.82%)

$233,967,000 (2772.88%)

Investments Non-Current

$0 (0%)

$1,658,000 (-85.56%)

$11,481,000 (-93.39%)

$173,693,000 (3343.56%)

Inventory

$3,155,000 (-81.63%)

$17,173,000 (-57.53%)

$40,436,000 (30.38%)

$31,015,000 (87.63%)

Trade & Non-Trade Receivables

$481,000 (-90.61%)

$5,121,000 (-68.58%)

$16,299,000 (-6.33%)

$17,401,000 (-58.45%)

Trade & Non-Trade Payables

$5,064,000 (-67.90%)

$15,778,000 (-48.70%)

$30,758,000 (17.86%)

$26,097,000 (5.28%)

Accumulated Retained Earnings (Deficit)

-$1,889,499,000 (-2.58%)

-$1,841,920,000 (-18.25%)

-$1,557,688,000 (-23.23%)

-$1,264,034,000 (-29.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$131,956,000 (-34.36%)

$201,027,000 (44.40%)

$139,218,000 (39.61%)

$99,720,000 (150.79%)

Debt Current

$0 (0%)

$12,647,000 (22.88%)

$10,292,000 (-5.96%)

$10,944,000 (-19.04%)

Debt Non-Current

$131,956,000 (-29.95%)

$188,380,000 (46.11%)

$128,926,000 (45.23%)

$88,776,000 (238.27%)

Total Liabilities

$398,160,000 (-32.02%)

$585,728,000 (-4.23%)

$611,567,000 (12.27%)

$544,708,000 (41.34%)

Liabilities Current

$133,306,000 (-38.76%)

$217,668,000 (-20.43%)

$273,562,000 (21.32%)

$225,497,000 (38.18%)

Liabilities Non-Current

$264,854,000 (-28.04%)

$368,060,000 (8.89%)

$338,005,000 (5.89%)

$319,211,000 (43.66%)

FGEN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$29,621,000 (-36.71%)

$46,803,000 (-66.74%)

$140,734,000 (-40.19%)

$235,309,000 (33.46%)

Cost of Revenue

$15,561,000 (292.76%)

$3,962,000 (-80.46%)

$20,280,000 (57.56%)

$12,871,000 (45.12%)

Selling General & Administrative Expense

$49,330,000 (-42.96%)

$86,483,000 (-30.64%)

$124,688,000 (0.62%)

$123,925,000 (16.46%)

Research & Development Expense

$95,692,000 (-64.09%)

$266,473,000 (-10.22%)

$296,791,000 (-23.32%)

$387,043,000 (53.03%)

Operating Expenses

$164,476,000 (-55.01%)

$365,562,000 (-13.27%)

$421,479,000 (-17.51%)

$510,968,000 (42.20%)

Interest Expense

$8,247,000 (1.88%)

$8,095,000 (462.15%)

$1,440,000 (33.95%)

$1,075,000 (-55.25%)

Income Tax Expense

-$269,000 (-6.75%)

-$252,000 (-170.39%)

$358,000 (3.17%)

$347,000 (-3.61%)

Net Loss Income from Discontinued Operations

-$105,519,000 (-172.39%)

-$38,738,000 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Weighted Average Shares

$4,001,760 (2.82%)

$3,892,120 (3.98%)

$3,743,280 (1.34%)

$3,693,960 (2.78%)

Weighted Average Shares Diluted

$4,001,760 (2.82%)

$3,892,120 (3.98%)

$3,743,280 (1.34%)

$3,693,960 (2.78%)

Earning Before Interest & Taxes (EBIT)

-$39,601,000 (85.67%)

-$276,389,000 (5.30%)

-$291,856,000 (-1.13%)

-$288,601,000 (-54.72%)

Gross Profit

$14,060,000 (-67.18%)

$42,841,000 (-64.43%)

$120,454,000 (-45.85%)

$222,438,000 (32.84%)

Operating Income

-$150,416,000 (53.39%)

-$322,721,000 (-7.21%)

-$301,025,000 (-4.33%)

-$288,530,000 (-50.37%)

FGEN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$125,993,000 (-18.00%)

$153,657,000 (72.42%)

$89,116,000 (120.87%)

-$426,972,000 (-194.36%)

Net Cash Flow from Financing

-$255,000 (-100.21%)

$122,749,000 (162.42%)

$46,776,000 (8408.35%)

-$563,000 (-104.22%)

Net Cash Flow from Operations

-$137,999,000 (56.19%)

-$315,021,000 (-115.87%)

-$145,933,000 (-77.46%)

-$82,232,000 (-200.77%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,510,000 (72.60%)

-$42,012,000 (-170.64%)

-$15,523,000 (96.94%)

-$507,170,000 (-191.86%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$656,000 (101.87%)

-$35,000,000 (-40.00%)

-$25,000,000 (-782.46%)

Net Cash Flow - Investment Acquisitions and Disposals

$125,213,000 (-19.49%)

$155,520,000 (21.64%)

$127,851,000 (132.22%)

-$396,786,000 (-186.39%)

Capital Expenditure

$780,000 (130.96%)

-$2,519,000 (32.56%)

-$3,735,000 (27.98%)

-$5,186,000 (-29.84%)

Issuance (Repayment) of Debt Securities

-$40,000 (-100.06%)

$70,848,000 (48.34%)

$47,759,000 (910.57%)

-$5,892,000 (54.76%)

Issuance (Purchase) of Equity Shares

$139,000 (-99.73%)

$52,138,000 (1146.13%)

$4,184,000 (-67.06%)

$12,701,000 (-66.43%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$751,000 (122.11%)

-$3,397,000 (38.03%)

-$5,482,000 (-311.09%)

$2,597,000 (-44.69%)

Share Based Compensation

$25,215,000 (-50.33%)

$50,767,000 (-22.61%)

$65,601,000 (-7.81%)

$71,161,000 (-2.14%)

Depreciation Amortization & Accretion

$2,692,000 (-72.89%)

$9,930,000 (-6.36%)

$10,604,000 (-28.39%)

$14,809,000 (-32.83%)

FGEN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

47.50% (-48.09%)

91.50% (6.89%)

85.60% (-9.42%)

94.50% (-0.53%)

Profit Margin

-160.60% (73.56%)

-607.30% (-190.99%)

-208.70% (-69.26%)

-123.30% (-14.80%)

EBITDA Margin

-124.60% (78.11%)

-569.30% (-184.93%)

-199.80% (-71.65%)

-116.40% (-24.76%)

Return on Average Equity (ROAE)

20.50% (-90.40%)

213.50% (148.48%)

-440.40% (-343.06%)

-99.40% (-126.94%)

Return on Average Assets (ROAA)

-16.70% (71.55%)

-58.70% (-32.51%)

-44.30% (-23.06%)

-36.00% (-55.84%)

Return on Sales (ROS)

-133.70% (77.36%)

-590.50% (-184.72%)

-207.40% (-69.17%)

-122.60% (-15.88%)

Return on Invested Capital (ROIC)

-22.40% (74.43%)

-87.60% (-4.16%)

-84.10% (-8.94%)

-77.20% (-30.19%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.1 (-262.83%)

-0.3 (94.04%)

-5.1 (-13.63%)

-4.49 (74.46%)

Price to Sales Ratio (P/S)

1.79 (-2.98%)

1.84 (-82.70%)

10.65 (92.50%)

5.53 (-70.72%)

Price to Book Ratio (P/B)

-0.24 (44.50%)

-0.43 (99.39%)

-70.18 (-1222.91%)

6.25 (-21.84%)

Debt to Equity Ratio (D/E)

-1.76 (38.48%)

-2.87 (89.94%)

-28.52 (-1195.05%)

2.6 (185.21%)

Earnings Per Share (EPS)

-12 (83.56%)

-73 (7.01%)

-78.5 (0.00%)

-78.5 (-48.82%)

Sales Per Share (SPS)

7.4 (-38.44%)

12.03 (-68.02%)

37.6 (-40.98%)

63.7 (29.85%)

Free Cash Flow Per Share (FCFPS)

-34.29 (57.97%)

-81.58 (-104.05%)

-39.98 (-68.95%)

-23.66 (-209.60%)

Book Value Per Share (BVPS)

-56.38 (-7.47%)

-52.46 (-815.62%)

-5.73 (-110.12%)

56.62 (-51.80%)

Tangible Assets Book Value Per Share (TABVPS)

53.61 (-50.74%)

108.82 (-33.23%)

162.98 (-22.20%)

209.48 (-8.94%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (80.00%)

-5 (-25.00%)

-4 (73.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.46 (-130.76%)

-0.63 (87.63%)

-5.13 (-23.64%)

-4.15 (76.36%)

Asset Turnover

0.1 (7.22%)

0.1 (-54.25%)

0.21 (-27.40%)

0.29 (35.19%)

Current Ratio

1.47 (-3.22%)

1.52 (-15.48%)

1.8 (-14.27%)

2.1 (-54.57%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$137,219,000 (56.79%)

-$317,540,000 (-112.16%)

-$149,668,000 (-71.21%)

-$87,418,000 (-212.64%)

Enterprise Value (EV)

$53,983,796 (-68.05%)

$168,938,936 (-88.28%)

$1,441,837,162 (27.03%)

$1,135,012,196 (-60.66%)

Earnings Before Tax (EBT)

-$47,848,000 (83.18%)

-$284,484,000 (3.00%)

-$293,296,000 (-1.25%)

-$289,676,000 (-53.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$36,909,000 (86.15%)

-$266,459,000 (5.26%)

-$281,252,000 (-2.72%)

-$273,792,000 (-66.46%)

Invested Capital

$162,693,000 (-49.99%)

$325,335,000 (1.65%)

$320,043,000 (-32.88%)

$476,821,000 (1805.61%)

Working Capital

$63,203,000 (-44.51%)

$113,891,000 (-48.06%)

$219,264,000 (-11.79%)

$248,562,000 (-58.01%)

Tangible Asset Value

$214,525,000 (-49.35%)

$423,529,000 (-30.58%)

$610,087,000 (-21.16%)

$773,821,000 (-6.41%)

Market Capitalization

$53,357,796 (-38.78%)

$87,158,936 (-94.21%)

$1,505,202,162 (15.15%)

$1,307,210,196 (-61.27%)

Average Equity

-$232,432,750 (-74.62%)

-$133,107,000 (-299.65%)

$66,671,750 (-77.14%)

$291,630,000 (-32.50%)

Average Assets

$284,504,250 (-41.27%)

$484,406,500 (-26.93%)

$662,911,750 (-17.66%)

$805,063,250 (-1.55%)

Invested Capital Average

$176,899,750 (-43.92%)

$315,414,250 (-9.09%)

$346,966,500 (-7.15%)

$373,668,750 (18.79%)

Shares

4,030,806 (2.47%)

3,933,609 (4.66%)

3,758,308 (1.35%)

3,708,398 (1.87%)